Health Canada
- Status: approved
🇨🇦 highly active antiretroviral therapy (HAART) in Canada
highly active antiretroviral therapy (HAART) (highly active antiretroviral therapy (HAART)) regulatory status in Canada.
Marketing authorisation
highly active antiretroviral therapy (HAART) in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in Canada
Frequently asked questions
Is highly active antiretroviral therapy (HAART) approved in Canada?
Yes. Health Canada has authorised it.
Who is the marketing authorisation holder for highly active antiretroviral therapy (HAART) in Canada?
National Institute of Allergy and Infectious Diseases (NIAID) is the originator. The local marketing authorisation holder may differ — check the official source linked above.